VJHemOnc is committed to improving our service to you

EHA 2020 | Extending the myeloma arena beyond BCMA

VJHemOnc is committed to improving our service to you

Hermann Einsele

Hermann Einsele, MD, FRCP, of the University of Würzburg, Würzburg, Germany, outlines studies investigating non-BCMA targets in multiple myeloma and their potential use in CAR-T cell therapy and bispecific antibodies. Such targets mentioned are GPRC5D, CD19, and SLAMF7. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter